Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade <i>IDH</i>-mutant diffuse gliomas.

Nancy Ann Oberheim Bush, J Costello, Javier Villanueva‐Meyer et al.|Journal of Clinical Oncology|2020

Cited by 4